#GenomicData
LightNews LightNews
nfdi.de
🏆️ 210+ datasets - and counting.
The #GHGA Data Portal is enabling cutting-edge genome research in Germany, providing secure access to data from oncology, rare diseases, and national initiatives. 🧬

🔗 data.ghga.de

#nfdi #genomicdata #fdm #rdm @ghga.bsky.social
October 16, 2026 at 8:31 AM
mdpm2026.bsky.social
🧬 Bioinformatics: Turning Biological Data into Precision Medicine

📅 June 17–18, 2027
📍 Zurich, Switzerland

Submit Abstract: advancedmoleculardx.com/abstract-sub...

#Bioinformatics #PrecisionMedicine #MolecularDiagnostics #Genomics #AI #GenomicData #NGS #PersonalizedMedicine #MDPM2027
September 23, 2026 at 12:32 PM
ergabiodiv.bsky.social
💬 Missed the latest #ERGAPlenary? No problem - catch up now on the #ERGAchannel with the keynote: #biodiversity genomes at @enasequence.bsky.social & the #ERGA Data Portal - talk by Joana Pauperio and Alexey Sokolov from @ebi.embl.org

▶️ youtu.be/gaS61VQzbCk?...

#data #genomes #genomicdata
Biodiversity Reference Genomes at ENA and the ERGA Data Portal - Joana Paupério & Alexey Sokolov
YouTube video by ERGA - European Reference Genome Atlas
youtu.be
November 19, 2025 at 1:46 PM
hetanshah.bsky.social
Google-backed genetic testing service 23andMe launches in UK #genomicdata http://gu.com/p/43n77
Domain Manage
Domain Manage
gu.com
December 6, 2024 at 7:39 PM
bbmrieric.bsky.social
💡 #GDI

#GDI Interview series

What does it take to build the infrastructure for #GenomicData across Europe?
buff.ly/7F9h5F1

How can genomics improve prevention, detection and personalised treatments?
buff.ly/CpObxjC

How can genomics transform healthcare across Europe?
buff.ly/C3EIYTY

🧵 9/10
October 16, 2025 at 7:00 AM
meduniwien.ac.at
📊🧬 How does local awareness shape #epidemicresponse?
A new study in @natcomms.nature.com combines #genomicdata from #SARSCoV2 with population surveys to trace behavioural adaptation during an outbreak.

📖 Read more ⬇️

#MedUniVienna #Epidemiology #COVID19
June 4, 2025 at 11:08 AM
novogene-europe.bsky.social
Join our December #webinar, presented by Prof. Uitterlinden of Complex Genetics, Erasmus MC, who will present on #WGS and the #GenomeOfEurope project.

Register here: bit.ly/4oC8fkH

#Genomics #1MillionGenomes #PrecisionMedicine #GenomicData #GeneticResearch #PersonalisedMedicine #Bioinformatics
Join Prof. André Uitterlinden: The Genome of Europe & the Future of Genomic
bit.ly
October 23, 2025 at 9:11 AM
onehealthtrust.bsky.social
Can AI predict #AMR?

A new #machinelearning model uses #genomicdata to identify AMR in Pseudomonas aeruginosa with up to 98% accuracy. Faster, smarter predictions for better patient care!

Read this article: academic.oup.com/bioinformati...

More digest: onehealthtrust.org/news-media/w...
academic.oup.com
September 24, 2025 at 6:26 AM
tamueccb.bsky.social
Howdy!

Join us on Friday for this week's ECCB Seminar!

🗓️ Friday, October 17th
📍 WFES 411 or Zoom: tamu.zoom.us/j/92751478457
🕛 12:00 - 1:00 PM

#TAMUECCB #Seminar #Ecology #Conservation #Biology #GenomicData
October 15, 2025 at 4:22 PM
idtdna.bsky.social
There’s still time to register for our next webinar! Join us to discover how targeted sequencing workflows are helping researchers generate high-quality #genomicdata, strengthen outbreak investigations, and better understand pathogen transmission:
https://ow.ly/ov5P50Zv4TM
August 6, 2026 at 3:00 PM
idtdna.bsky.social
Ready to shape insights into research action? Molecular Health's variant annotation and reporting software is designed to equip you with easy-to-use tertiary analysis for your #NGSdata, maximizing #labefficiency, and streamlining #genomicdata workflows. Request a consultation: https://idtb.io/r4mhrw
December 20, 2025 at 4:45 PM
idtdna.bsky.social
Interested in learning more about Molecular Health's tertiary analysis software? 🤔

Request a free workflow consultation with us! Maximize your lab’s efficiency and streamline your #genomicdata workflows.

Start here: https://idtb.io/r4mhrw
November 25, 2025 at 5:02 PM
idtdna.bsky.social
💥FREE CONSULTATION!💥
Molecular Health's variant annotation and reporting software is designed to equip you with easy-to-use tertiary analysis for your #NGS data, maximizing #labefficiency, and streamlining #genomicdata workflows.

👐Shape insights into research action. Request a demo: idtb.io/r4mhrw
October 27, 2025 at 5:11 PM
elixir-europe.org
📣 The ELIXIR-coordinated EU project, #B1MGplus, is conducting a survey on 💡 the use, access, governance and sustainability of #genomicdata and related services. Provide your insights to 🎯 support the development of a sustainable European genomic data infrastructure. 👉 https://loom.ly/4uSHoak
May 15, 2026 at 10:01 AM
elixir-europe.org
📣 The European Genomic Data Infrastructure project coordinated by ELIXIR released three videos about the #1MGenomes Initiative.
🤔 The videos explain "What is the 1+MG Initiative?" & "How will the Initiative benefit citizens and healthcare providers?"

#genomicdata #datasharing
What is the 1+Million Genomes Initiative?
What is the 1+Mililion Genomes Initiative? How will the Initiative benefit you?Genomics has the potential to revolutionise healthcare through the development...
youtu.be
March 13, 2025 at 11:00 AM
genomebc.bsky.social
The theme of yesterday's panel on “Canada’s Genomic Future: Ethics, Data Sovereignty & Defence,” at the Life Sciences BC
#AccessToInnovation conference: We are entering an era where #GenomicData is no longer just a medical resource; it is a strategic national asset.
February 26, 2026 at 5:52 PM
ribozyme.bsky.social
🧬🖥️  Once formally published, we'll release the raw sequence data of the cell lines used in our benchmarking. This resource will aid others developing new tools and settings within WES sequencing. Stay tuned! #GenomicData
July 19, 2024 at 7:56 PM
protechbro.bsky.social
A New York Times article indicates that customers of the genetic data company 23andMe might face greater risks than they are aware of The article says that the company’s problems may not last long compared to the longer-term threats those 15 million people will face if… #Tech #23andMe #GenomicData
23andMe’s Future Sparks Concerns Over Genomic Data
A New York Times article indicates that customers of the genetic data company 23andMe might face greater risks than they are aware of The article says that the company’s problems may not last long compared to the longer-term threats those 15 million…
protechbro.com
October 7, 2024 at 3:52 PM
eleningogos.bsky.social
Today at 9:30am EST - Overview of the NIH Security Best Practices for Users of Controlled-Access Data: a virtual overview & Q/A ahead of the January 25th implementation of updated security standards.

Register: nih.zoomgov.com/meeting/regi...

#genomicdata #datamanagement
Meeting Registration - Zoom
nih.zoomgov.com
January 8, 2025 at 1:56 PM
erdera.bsky.social
🔬 Exciting news: ERDERA joins forces with the European Genomic Data Infrastructure project (GDI) to advance rare disease research and diagnosis across Europe. Launching 14 Oct in Paris. 🌍 👉 Read more: https://loom.ly/7lthRbQ
#RareDiseases #GenomicData #1MGenomes
ERDERA and the European Genomic Data Infrastructure project work together to strengthen rare disease data, diagnostics and research - ERDERA
Fruitful collaboration ahead
erdera.org
October 13, 2025 at 4:23 PM
pharmaphorum.bsky.social
#BasecampResearch has launched a new scientific initiative, called the #TrillionGeneAtlas, to bring together #genomicdata from millions of species and use it to guide and scale #AI-powered design of #newtherapeutics.
Basecamp lifts veil on Trillion Gene Atlas genomics push
Basecamp Research's Trillion Gene Atlas will bring together genomic data from millions of species to guide AI-powered design of new medicines.
buff.ly
March 18, 2026 at 4:30 PM
pharmaphorum.bsky.social
#MSD has signed a deal with the #MayoClinic that will allow it to use the health system's #genomicdata and #clinicaldata for #drugdiscovery.

pharmaphorum.com/news/msd-and...
MSD and Mayo Clinic team up on AI drug discovery
MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.
pharmaphorum.com
February 19, 2026 at 9:47 AM
jsantoyo.bsky.social
Methodological opportunities in genomic data analysis to advance health equity. #GenomicData #DataAnalysis #HealthEquity #Genomics #Bioinformatics @natrevgenet.nature.com 🧬 🖥️
www.nature.com/articles/s41...
July 3, 2025 at 9:15 AM
jsantoyo.bsky.social
SampleExplorer: Using language models to discover relevant transcriptome data. #RNAseq #DataSearch #GenomicData #Genomics #Bioinformatics 🧬 🖥️
academic.oup.com/bioinformati...
SampleExplorer: Using language models to discover relevant transcriptome data
AbstractMotivation. Over the last two decades, transcriptomics has become a standard technique in biomedical research. We now have large databases of RNA-s
academic.oup.com
January 6, 2025 at 8:13 PM
jlme-journal.bsky.social
New open-access on FirstView: "Regulatory Guidance for the Return of Raw Genomic Data to Research Participants: A Qualitative Interview Study" by Jane Louise Nielsen, Claire E. Wakefield, @bekmc.bsky.social et al.
#ELSI #GenomicData
www.cambridge.org/core/journal...
Regulatory Guidance for the Return of Raw Genomic Data to Research Participants: A Qualitative Interview Study Jane Louise Nielsen1, Claire E. Wakefield2,3,4, Rebekah McWhirter5, Carolyn Johnston1, Margaret Otlowski1 , Vanessa Tyrrell6,7, Mark J. Cowley6,7, Katherine M. Tucker6,7,8, Ruth Lyons9, and Anthony J. Gill9,10,11,12 1Faculty of Law, University of Tasmania, Australia; 2Department of Pediatrics, Stanford University and Stanford Medicine Children’s Health, Palo Alto, United States; 3School of Clinical Medicine, University of New South Wales, Australia; 4Kids Cancer Centre, Sydney Children’s Hospital Randwick, Australia; 5Australian National University, Australia; 6Zero Childhood Cancer Program, Children’s Cancer Institute, Australia; 7University of New South Wales, Australia; 8Sydney Children’s Hospital Network, Australia; 9Garvan Institute of Medical Research, Australia; 10Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, Australia; 11NSW Health Pathology, Australia and 12Faculty of Medicine and Health, University of Sydney, Australia Abstract This paper reports the results of an Australian qualitative study investigating the return of raw genomic data to research study participants. Increasing numbers of participants request access to their raw genomic data, although the legal position in relation to whether data should be returned lacks clarity, particularly in Australia. Interviews were conducted with stakeholders involved in two research studies where participants have undergone whole genome sequencing: ZERO Childhood Cancer, and the Australian Pancreatic Cancer Genome Initiative. Four major themes were identified: whether raw genomic data should be returned; reasons for seeking access; risks in returning data; and processes for return. Our findings indicate that health professionals, scientists, bioinformaticians, patients and patient advocates overwhelm- ingly support the return of raw data upon request, with ethical imperatives pr…
June 10, 2026 at 3:41 PM